T. Rowe Price Investment Management, Inc. Immunome Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Immunome Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 3,878,595 shares of IMNM stock, worth $45 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,878,595
Previous 1,516,454
155.77%
Holding current value
$45 Million
Previous $37.4 Million
25.39%
% of portfolio
0.03%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding IMNM
# of Institutions
118Shares Held
43.5MCall Options Held
67.2KPut Options Held
65.9K-
Redmile Group, LLC San Francisco, CA4.89MShares$56.7 Million3.86% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$45 Million1.66% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$43.6 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.16MShares$36.7 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$33.9 Million0.0% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $141M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...